Frontlight ResearchEarly access
Polycystic kidney disease trials in Hong Kong
1 trial · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peoplePhase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003
- Where
- Shatin
- Age
- 18 years to 65 years
- People
- 166 worldwide
- Run by
- PYC Therapeutics
See details and how to joinNCT06714006